Testing effectiveness (Phase 2)Study completedNCT02243358
What this trial is testing
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Who this might be right for
Pancreas Neoplasm Malignant Resectable
Henry Ford Health System 24